Anti-Neoplastic Agents Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts, 2016–2024

Report Code: ZMR-3024 | Report Format : | Status : Upcoming |

Abstract

Global Anti-Neoplastic Agents Market: Overview

Anti-neoplastic agents are primarily used as a first-line treatment for cancer therapy as well as in combination with radiation or surgical therapy. A lot of anti-neoplastic agents are accessible commercially for the therapy of various kinds of cancers which includes Gleevec, Oncotrex, Cytarine, Leukeran, Neosar, etc.

Global Anti-Neoplastic Agents Market: Growth Factors

Anti-neoplastic agents are majorly utilized in combination with immunotherapy, surgery, hormone therapy, radiotherapy, and targeted therapy for several solid tumors, particularly metastatic. The risk associated with cancer grows along with age and it is now becoming more common across the world owing to the quickly changing standard of living of individuals. Therefore, growing demand and requirement for anti-neoplastic agents has attracted the attention of several key pharmaceutical companies to get into the global anti-neoplastic agents market and expand more competent drugs against numerous cancer conditions.

Growing occurrence of cancer cases, increasing funding from government bodies, technological advancements, and favorable reimbursement policies are the most important aspects fuelling the development of global anti-neoplastic agents market. On the other hand, aspects such as lack of knowledge about cancer condition in emerging regions and technological complexities linked with the existing diagnostic examination would hold back the development of the global anti-neoplastic agents market.

Global Anti-Neoplastic Agents Market: Segmentation

The global market for anti-neoplastic agents is classified in terms of the end user, product type, and region. In terms of product type, anti-neoplastic agents market is fragmented into biological or immunotherapeutic agents, chemotherapeutic agents, and personalized medicine. In terms of the end user, the global market has been categorized into clinics, hospitals, ambulatory surgical centers, and cancer rehabilitation center. Hospital end user division is projected to contribute the highest share amongst end users.

Global Anti-Neoplastic Agents Market: Regional Analysis

In terms of region, Europe and North America are likely to be the leading regional markets with potential revenue opportunity for the global anti-neoplastic agents market. The U.K, Germany, and the U.S. are likely to witness high acceptance for anticancer drugs when compared with other provinces owing to advanced healthcare infrastructure, the rise in the number of NGOs that work for cancer management, targeted efforts of government, the high prevalence of the disease, and occurrence of unhealthy lifestyle in the regions.

The market for anti-neoplastic in the Asia Pacific is projected to witness development at a quick pace. Developed regions such as Japan and Australia are likely to witness favorable market development. Increasing occurrence of different forms of cancer, projected pipeline drugs, growing disposable incomes, and increased knowledge regarding the advantages of early diagnosis are the factors that are expected to fuel the market development of the regional market. China and India are likely to be the most attractive markets due to high occurrences of the syndrome and the presence of the recognized market players.

Global Anti-Neoplastic Agents Market: Competitive Players

Some of the most important market players in the global anti-neoplastic agents market are AbbVie Inc., Amgen Inc., Hoffmann-La Roche Ltd., Baxter Healthcare Corporation, Bristol-Myers Squibb Company, Aspen Global Inc., Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Bayer AG, Merc & Co., Inc., Johnson & Johnson Pvt. Ltd., Accord Healthcare, Inc., Pfize Inc., Lundbeck LLC, and Genentech, Inc., among others.

Global Anti-Neoplastic Agents Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • The UK
    • France
    • Germany
  • The Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Hydroxychloroquine Market - By Type (USP Standards Grade, Pharmaceutical Standards Grade, EP Standards Grade, and Others), By Application (Rheumatoid Arthritis, Skin Lesions, Systemic Lupus Erythematosus, Chronic Discoid Lupus Erythematosus, and Others), and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Apr-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5346 | Report Format:

The global Hydroxychloroquine market value was estimated at 542 (USD Million) in 2019 and is projected to hit 5,000 (USD Million) by 2025 growing at a CAGR of over 33% during the period from 2019 to 2025. The report offers valuation and analysis of the Hydroxychloroquine market on a global as well...Read More

Hyperhidrosis Treatment Market: By Treatment Type (Botulinum Toxin A, Non-Surgical Microwave Energy Destruction of Sweat Glands, Iontophoresis, Topical Treatments, Surgical Treatments, and Others), By Type (Axillary Hyperhidrosis, Plantar Hyperhidrosis, Palmar Hyperhidrosis, and Others), and By End-User (Hospitals, Ambulatory Surgical Centers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Jan-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5214 | Report Format:

The report includes Revenue forecast analysis of the hyperhidrosis treatment market on a global as well as regional level. It also offers historic data of 2016 and 2017 and provides a valuation of the industry surge during 2019-2025 in terms of USD Billion. Our study includes competitive strategi...Read More

Home Blood Pressure Monitoring Devices Market: by Product (Upper Arm Monitors, Wrist Monitors, and Accessories), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Other Distribution Channels): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025

Dec-2019 | Price : $ 4199.00 | Pages: 130 | Report Code: ZMR-5131 | Report Format:

According to the report, global demand for home blood pressure monitoring devices market was valued at USD 1,093.1 million in 2018, and is expected to generate revenue of USD 1,611.3 million by end of 2025, growing at a CAGR of 5.7% between 2019 and 2025 The report covers forecast and analysis f...Read More

Orthostatic Hypotension Drugs Market: by Diagnostic Test Type (ECG, Blood Tests, Stress Test and Other), Drug Type (Midodrine, Northera (droxidopa), Fludrocortisone, Caffeine and Others) and End user (Hospitals, ASCs and Clinics and Others) – Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025

Dec-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5123 | Report Format:

The report covers forecast and analysis for the Orthostatic Hypotension Drugs market on a global and regional level. The study provides historic data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the Orthosta...Read More

Carcinoembryonic Antigen Market: by Application (Thyroid Cancer, Prostate Cancer, Ovarian Cancer, Lung Cancer, Breast Cancer, Gastrointestinal Cancer and Other Applications); by End User (Research and Academic Institutes, Diagnostic Centers, Hospitals and Other End Users): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Dec-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5122 | Report Format:

The report covers forecast and analysis for the carcinoembryonic antigen market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the carcinoembryonic antige...Read More

Request Brochure

COVID-19

A Global Pandemic

Request the coronavirus impact analysis across industries and market

Request impact analysis on this market
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.